Lunai Bioworks Inc. Accumulated Other Comprehensive Income
Lunai Bioworks Inc. (LNAI) had Accumulated Other Comprehensive Income of -$155.70 thousand as of 2026-03-31, per its 10-Q filed 2026-05-15.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2026-05-15
- 2026-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$155.70K.
- 2025-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$139.02K.
- 2025-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$128.16K.
- 2025-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $10.81M.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax |
|---|---|
| 2026-03-31 | -$155.70K 10-Q · filed 2026-05-15 |
| 2025-12-31 | -$139.02K 10-Q · filed 2026-02-17 |
| 2025-09-30 | -$128.16K 10-Q · filed 2025-11-14 |
| 2025-06-30 | $10.81M 10-Q · filed 2026-05-15 |
| 2025-03-31 | $775.61K 10-Q · filed 2025-05-15 |
| 2024-12-31 | -$3.85M 10-Q · filed 2025-02-19 |
| 2024-09-30 | $6.30M 10-Q/A · filed 2025-02-19 |
| 2024-06-30 | -$170.85K 10-K · filed 2025-09-29 |
| 2024-03-31 | $1.03M 10-Q/A · filed 2025-02-19 |
| 2023-12-31 | -$27.23K 10-Q · filed 2024-02-14 |
| 2023-09-30 | -$64.48K 10-Q · filed 2023-11-14 |
| 2023-06-30 | -$29.88K 10-Q/A · filed 2025-02-19 |
| 2023-03-31 | -$32.38K 10-Q · filed 2023-05-12 |
| 2022-12-31 | -$30.27K 10-Q · filed 2023-03-09 |
| 2022-09-30 | -$38.19K 10-Q · filed 2023-03-07 |
| 2022-06-30 | -$30.44K 10-K · filed 2023-10-02 |
| 2022-03-31 | -$21.49K 10-Q · filed 2022-05-13 |
| 2021-12-31 | -$18.82K 10-Q · filed 2022-02-14 |
| 2021-09-30 | -$14.83K 10-Q · filed 2021-11-15 |
| 2021-06-30 | -$10.83K 10-K · filed 2023-02-27 |
| 2021-03-31 | -$12.92K 10-Q · filed 2021-05-17 |
| 2020-12-31 | -$3.09K 10-Q · filed 2021-02-16 |
| 2020-09-30 | -$13.03K 10-Q · filed 2020-11-12 |
| 2020-06-30 | -$41.42K 10-K · filed 2021-09-24 |
| 2020-03-31 | -$55.74K 10-Q · filed 2020-05-11 |
| 2019-12-31 | -$45.55K 10-Q · filed 2020-02-10 |
| 2019-09-30 | -$176.84K 10-Q · filed 2019-11-13 |
| 2019-06-30 | $101.82K 10-K · filed 2020-09-23 |
| 2019-03-31 | $198.82K 10-Q · filed 2019-05-16 |
| 2018-12-31 | $338.53K 10-Q · filed 2019-02-13 |
| 2018-09-30 | $114.16K 10-Q · filed 2018-11-14 |
| 2018-06-30 | $205.68K 10-K · filed 2019-09-30 |
| 2018-03-31 | -$267.71K 10-Q · filed 2018-05-15 |
| 2017-12-31 | -$31.75K 10-Q · filed 2018-02-09 |
| 2017-09-30 | $97.65K 10-Q · filed 2017-11-20 |
| 2017-06-30 | $352.83K 10-K · filed 2018-10-01 |
| 2017-03-31 | $835.28K 10-Q · filed 2017-05-15 |
| 2016-12-31 | $942.85K 10-Q · filed 2017-02-14 |
| 2016-09-30 | $538.71K 10-Q · filed 2016-11-14 |
| 2016-06-30 | $564.29K 10-K · filed 2017-11-20 |
| 2016-03-31 | $382.70K 10-Q · filed 2016-05-13 |
| 2015-12-31 | $680.30K 10-Q · filed 2016-02-12 |
| 2015-09-30 | $533.78K 10-Q · filed 2015-11-13 |
| 2015-06-30 | $543.59K 10-K · filed 2016-09-28 |
| 2015-03-31 | $717.82K 10-Q · filed 2015-05-13 |
| 2014-12-31 | $275.25K 10-KT · filed 2015-09-28 |
| 2014-09-30 | $199.51K 10-Q · filed 2014-11-13 |
| 2014-06-30 | -$16.11K 10-Q · filed 2014-08-14 |
| 2014-03-31 | -$27.84K 10-Q · filed 2014-05-14 |
| 2013-12-31 | -$31.19K 10-KT · filed 2015-09-28 |
| 2012-12-31 | $188.28K 10-Q · filed 2014-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |